Engineered fatty acid biosynthesis in Streptomyces by altered catalytic function of β-ketoacyl-acyl carrier protein synthase III

被引:23
|
作者
Smirnova, N
Reynolds, KA
机构
[1] Virginia Commonwealth Univ, ISBDD, Richmond, VA 23219 USA
[2] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA
关键词
D O I
10.1128/JB.183.7.2335-2342.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Streptomyces glaucescens beta -ketoacyl-acyl carrier protein (ACP) synthase III (KASIII) initiates straight- and branched-chain fatty acid biosynthesis by catalyzing the decarboxylative condensation of malonyl-ACP with different acyl-coenzyme A (CoA) primers. This KASIII has one cysteine residue, which is critical for forming an acyl-enzyme intermediate in the first step of the process. Three mutants (Cys122Ala, Cys122Ser, Cys122Gln) were created by site-directed mutagenesis, Plasmid-based expression of these mutants in S. glaucescens resulted in strains which generated 75 (Cys122Ala) to 500% (Cys122Gln) more straight-chain fatty acids (SCFA) than the corresponding wild-type strain. In contrast, plasmid-based expression of wild-type KASIII had no effect on fatty acid profiles. These observations are attributed to an uncoupling of the condensation and decarboxylation activities in these mutants (malonyl-ACP is thus converted to acetyl-ACP, a SCFA precursor). Incorporation experiments with perdeuterated acetic acid demonstrated that 9% of the palmitate pool of the wild-type strain was generated from an intact D-3 acetyl-CoA starter unit, compared to 3% in a strain expressing the Cys122Gln KASIII. These observations support the intermediacy of malonyl-ACP in generating the SCFA precursor in a strain expressing this mutant. To study malonyl-ACP decarboxylase activity in vitro, the KASIII mutants were expressed and purified as His-tagged proteins in Escherichia coli and assayed. In the absence of the acyl-CoA substrate the Cys122Gln mutant and wild-type KASIII were shown to have comparable decarboxylase activities in vitro. The Cys122Ala mutant exhibited higher activity. This activity was inhibited for all enzymes by the presence of high concentrations of isobutyryl-CoA (>100 muM), a branched chain fatty acid biosynthetic precursor. Under these conditions the mutant enzymes had no activity, while the wild-type enzyme functioned as a ketoacyl synthase. These observations indicate the likely upper and lower limits of isobutyryl-CoA and related acyl-CoA concentrations,within S. glaucescens.
引用
收藏
页码:2335 / 2342
页数:8
相关论文
共 50 条
  • [21] Structure and substrate specificity of -ketoacyl-acyl carrier protein synthase III from Acinetobacter baumannii
    Lee, Woo Cheol
    Jeong, Min-Cheol
    Lee, Yeongjoon
    Kwak, Chulhee
    Lee, Jee-Young
    Kim, Yangmee
    MOLECULAR MICROBIOLOGY, 2018, 108 (05) : 567 - 577
  • [22] Review of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH)
    Shang, Ruofeng
    Liang, Jianping
    Yi, Yunpeng
    Liu, Yu
    Wang, Jiatu
    MOLECULES, 2015, 20 (09): : 16127 - 16141
  • [23] Expression, purification, and crystallization of the Escherichia coli selenomethionyl β-ketoacyl-acyl carrier protein synthase III
    Khandekar, SS
    Konstantinidis, AK
    Silverman, C
    Janson, CA
    McNulty, DE
    Nwagwu, S
    Van Aller, GS
    Doyle, ML
    Kane, JF
    Qiu, XY
    Lonsdale, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (01) : 100 - 107
  • [24] Molecular characterization of Lactobacillus plantarum genes for β-ketoacyl-acyl carrier protein synthase III (fabH) and acetyl coenzyme A carboxylase (accBCDA), which are essential for fatty acid biosynthesis
    Kiatpapan, P
    Kobayashi, H
    Sakaguchi, M
    Ono, H
    Yamashita, M
    Kaneko, Y
    Murooka, Y
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (01) : 426 - 433
  • [25] Expression, purification and crystallization of the Escherichia coli selenomethionyl β-ketoacyl-acyl carrier protein synthase III
    Khandekar, SS
    Konstantinidis, AK
    Silverman, C
    Janson, CA
    McNulty, DE
    Nwagwu, S
    Van Aller, GS
    Doyle, ML
    Qiu, X
    Lonsdale, J
    FASEB JOURNAL, 2000, 14 (08): : A1322 - A1322
  • [26] Characterization of β-ketoacyl-acyl carrier protein synthase II homologues in Enterococcus faecalis
    Wang Yu-Qi
    Sun Yi-Rong
    Chen Yi-Cai
    Wang Hai-Hong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (08) : 844 - 850
  • [27] Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design
    Lu, X. Y.
    Tang, J.
    Zhang, Z.
    Ding, K.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 651 - 667
  • [28] Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae β-ketoacyl-acyl carrier protein synthase III (FabH)
    Khandekar, SS
    Gentry, DR
    Van Aller, GS
    Warren, P
    Xiang, H
    Silverman, C
    Doyle, ML
    Chambers, PA
    Konstantinidis, AK
    Brandt, M
    Daines, RA
    Lonsdale, JT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 30024 - 30030
  • [29] Novel E-coli β-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics
    Lee, Jee-Young
    Jeong, Ki-Woong
    Lee, Ju-Un
    Kang, Dong-Il
    Kim, Yangmee
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (04) : 1506 - 1513
  • [30] Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
    Li, Huan-Qiu
    Luo, Yin
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4454 - 4459